Been waiting for a new entry point on this stellar company. Tesla has only had a couple of second chances for longs to get long or else they miss the biggest moves. All the fear is giving us this opporetuni9ty.
Wrong. Shedding alone is not what matters to the FDA, clinical endpoints do. And when the placebo has better clinical endpoints than all of your study drug combinations which is the case with Genocea, then there is a significant problem there. You are deluding yourself if you think that is not a big problem.
I guarantee you GNCA is working hard to modify their study design in hopes of somehow eliminating and or preventing this claimed placebo effect from ruining future studies because from here on out, errors will result in delayed or non approval and a decimated stock price.
Yep, UBER is a software based model which allows for a much higher valuation premium than a hardware provider of a soon to be commodity product that cannot block competition from coming in and killing gross margins.
Ask yourself what PE multiples all of the iphone parts suppliers enjoy and then compare this company to that. That is more of a apples to apples comparison and it would put AMBA's price at closer to $30-$60/share.
So its even worse than people think.
After plummeting from $8. OREX just a few days back did 7 clear bounces off of $4.80 before it finally punched down through it hard to $4.30.
What was your point again?
I remember that big fight in VVUS about firing CEO's and the like just like ARNA is starting to do now.
Typical human survival behavior when sh !! !T is about to hit the fan.
With the current rate of flat script growth it would even be difficult to defend a 500 million valuation.
The problem is simply that Americans do not really care about losing weight and the true obesity market is much much smaller than everyone thought.
Has TEVA officially filed for a Contrave ANDA with the FDA yet? Because that's coming down the pipe too and realistically I don't see Orex winning against the generic drug makers in their suit.
Script growth has also reversed so expect a BIG earnings miss for Q2 and expect some big downward earnings revisions coming soon.
Your god doesn't even exist you terrorist nutto head. Electing leaders who believe in delusions is generally not a good thing. Just look at the middle east where religious rule is the law. Believing delusions is ALWAYS bad. Always.
Clearly, the only persons spinning here are the longs where joseph lied and accused me of spinning last weeks numbers and now you accuse me of spinning this weeks numbers. HILARIOUS! Instead of constantly looking for excuses I would counsel you to consider that revealing that your drug has a higher death rate than placebo is actually hurting prescriptions. OREX lost more scripts than all the other weight loss drugs this past week, why?. And OREX lost 400 scripts in the week before that, why?. And OREX gained the least amount of scripts (only 100) in the week before that, why?
The answer is right in front of you if you'd just remove your beer goggles and biases, you would see it.
In a span of 3 weeks, OREX has gone from the best weekly performing obesity drug............to now the worst weekly performing and that just happens to coincide exactly with the very poor 50% data release.
The only person spinning are the longs where joseph lied and accused me of spinning last weeks numbers and now you accuse me of spinning this weeks numbers. HILARIOUS! Instead of constantly looking for excuses I would counsel you to consider that revealing that your drug has a higher death rate than placebo will actually hurt prescriptions. OREX lost more scripts than all the other weight loss drugs this past week, why?. And OREX lost 400 scripts in the week before that, why?. And OREX gained the least amount of scripts (only 100) in the week before that, why?
The answer is right in front of you if you'd just remove your beer goggles.
First you should understand that OREX was in the 3's and heading lower when OREX shot up due to funds getting leaked the 25% data in the first place. Now that the 25% data has been proven fake and that it's more likely OREX increases the risk of death, you should fully expect OREX to retest those lows in the 3's. Anyone holding here is just asking to lose their money IMO. Better to buy around $3.40 with a stop and then hope it bounces off it's 2014 lows.
The decline is real now as OREX has put in its first ever multiweek decline.
Only an idiot or the naive would think that the horrible health data from the cancelled study would not give doctors pause to prescribe Contrave. No way no how can OREX justify their bloated 600 million mkcap so you better get out now before the fund managers beat you to it and you wake up with OREX at 2 bucks.